Ensign Peak Advisors
AURA icon

Ensign Peak Advisors’s Aura Biosciences AURA Stock Holding History

Ensign Peak Advisors’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-390,695
Closed -$3.21M – 1691
2024
Q4 		$3.21M Buy
390,695
+118,000
+43% +$1.11M 0.01% 776
2024
Q3 		$2.43M Buy
272,695
+20,789
+8% +$178K ﹤0.01% 866
2024
Q2 		$1.9M Sell
251,906
-105,316
-29% -$771K ﹤0.01% 930
2024
Q1 		$2.8M Hold
357,222
– – 0.01% 801
2023
Q4 		$3.16M Buy
+357,222
New +$3.03M 0.01% 747

Other funds holding AURA

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Ensign Peak Advisors's AURA Position: Q1 2025 in Review

Ensign Peak Advisors sold out of Aura Biosciences (AURA) in Q1 2025, closing a stake of 390,695 shares — an estimated $3.21M sold.

Ensign Peak Advisors first reported a position in AURA in Q4 2023 and held it in 5 quarters. The position peaked at $3.21M in Q4 2024. 94 funds tracked by Wall St. Rank hold AURA as of Q1 2025.

  • Ensign Peak Advisors reported no remaining Aura Biosciences position as of Q1 2025 after selling out during the quarter.
  • Ensign Peak Advisors sold 390,695 Aura Biosciences shares in Q1 2025, an estimated $3.21M.
  • Ensign Peak Advisors first reported a position in Aura Biosciences in Q4 2023 and held it in 5 quarters.
  • Ensign Peak Advisors's Aura Biosciences position peaked at $3.21M in Q4 2024.
  • 94 funds tracked by Wall St. Rank held Aura Biosciences as of Q1 2025.

Based on Ensign Peak Advisors's 13F filing for Q1 2025, filed 14 May 2025.